PlasmaSelect AG Acquires All Assets of CuraMED Pharma GmbH
MARTINSRIED, September 19, 2003 - PlasmaSelect AG herewith announces that as of July 1, 2004 its subsidiary DeltaSelect GmbH has acquired all assets of CuraMED Pharma GmbH, a 100 % subsidiary of Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe.
The revenues of CuraMED reached 13.7 Mio. € in 2003 with a positive EBIT. The purchase price will be kept confidential.
CuraMED is actively selling i.v. generic injectables in Germany and in smaller amount also internationally. These injectables are dedicated to anesthesia, intensive care and pain management. CuraMED has reached a leading position in this health care segment in Germany. Schwabe has decided to further on concentrate on its core business phytopharmaceuticals and therefore concluded willing to divest CuraMED.
The product portfolio of CuraMED ideally fits into the one of DeltaSelect GmbH, as it is expanding and strengthening it and in addition is addressing the same customers already served by DeltaSelect GmbH. Thus DeltaSelect GmbH - after having integrated the products of CuraMED GmbH - will be able to generate considerable synergies out of purchasing, logistics and sales.
The profitability of DeltaSelect GmbH is going to be further increased by this acquisition.
PlasmaSelect AG The Managing Board